Movicol Orange

Macrogol 3350, the active ingredient in Movicol Orange, is a osmotic laxative presented as a oral solution for oral use. It treats constipation and chronic constipation in adults and children as appropriate.

GNH USA supplies Movicol Orange as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Orange is an osmotic laxative used to manage conditions affecting bowel motility.

Constipation: provides relief of occasional constipation by increasing stool water content. Chronic constipation: helps maintain regular bowel movements in patients with long‑term constipation. Bowel preparation adjunct: may be used under medical supervision to soften stool before diagnostic procedures.

Common Side Effects: - Abdominal bloating or distension. - Nausea or mild stomach discomfort. - Flatulence or increased gas. - Diarrhoea, especially with higher doses. - Thirst or mild dehydration.

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatraemia, hypokalaemia). - Acute renal impairment in susceptible individuals. - Allergic reactions such as rash, urticaria, or angioedema. - Persistent diarrhoea leading to dehydration. - Severe abdominal pain indicating obstruction.

Before using Movicol Orange, consider the following precautions: - Renal function: assess kidney health, especially in patients with chronic kidney disease. - Electrolyte status: monitor serum electrolytes in patients at risk of imbalance. - Gastrointestinal obstruction: avoid use if there is known or suspected bowel blockage. - Dehydration risk: ensure adequate fluid intake to prevent excessive fluid loss. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Potential drug interactions should be reviewed prior to therapy.

Major Interactions (Avoid): - Concomitant use with potent diuretics may exacerbate electrolyte disturbances. - Co‑administration with other osmotic laxatives can increase risk of severe diarrhoea and dehydration.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium or magnesium may alter electrolyte balance when taken together. - Certain antibiotics (e.g., quinolones) may have reduced absorption if taken simultaneously; separate dosing by at least 2 hours.